Which of Your Strengths Are Competitive, and Which Are Merely Common?
Reliability and responsiveness are entry conditions, not differentiators. A strength list is a capital allocation instrument disguised as a description of the firm.
Professional knowledge and strategic perspectives across strategy, projects, operations, engineering, transformation and business performance.
47 articles found
Reliability and responsiveness are entry conditions, not differentiators. A strength list is a capital allocation instrument disguised as a description of the firm.
Uncertainty is not a reason to delay planning. It is the strongest argument for starting early, and for changing what a plan is expected to do.
Most enterprises size their market by who is afflicted now. The market defined by avoidance is larger, buys on different logic, and needs a different model.
Why strategy requires explicit choices about value, focus, capability and trade-offs rather than an expanding list of priorities and projects.
What historical CEO performance research reveals about incentives, long-term value creation and the strategic consequences of measuring the wrong horizon.
Some risk treatments lower the chance of the event. The rest only decide who pays when it happens. Most registers cannot tell you which one you bought.
Every serious estimate arrives with a range around it. The number that leaves the approval meeting has none, and nobody decided to remove it.
An absolute constraint abolishes acceptance and most of transfer, leaving only the two costliest risk responses — and that price never returns to the business case.
How leaders can use the business case as a continuing investment control that tests strategic value, benefits, cost, risk and the case for stopping.
How executives can define project scope as an investment boundary connecting strategic need, deliverables, acceptance and organisational value.
Why project change control should evaluate value, opportunity cost, risk and capacity—not merely approve modifications to scope, cost or schedule.
Method, training and certification are funded as capability. Some of it becomes an organisational asset and some of it walks out the door. Few business cases say which.
A priority label is not a statement of importance. It declares which variable the organisation has agreed to let move — and \"critical\" means resources are it.
A gate that has never stopped anything is not a control. It is a status review with a budget attached, and the portfolio is paying for the difference.
Filed under quality and run during delivery, a value study can only cut cost. Its real question — what is this element for? — has to be asked before commitment.
Why approving individually attractive projects can destroy portfolio value when capacity, dependencies, opportunity cost and strategic focus are ignored.
Treat the portfolio as a strategic feedback system that senses change, reallocates resources and keeps investment decisions aligned with enterprise value.
A practical portfolio rebalancing method for deciding which initiatives to stop, defer, redesign or accelerate as evidence and strategy change.
Why leaders must distinguish execution failure from bad strategic selection, portfolio overreach and capability mismatch before adding more control.
Why governments must separate the decision to invest in infrastructure from the later choice of PPP financing and procurement structure for delivery.
Portfolio management is an executive investment discipline for allocating scarce capital, capability and attention to the initiatives that matter most.
A portfolio function that chooses between investments and one that oversees work already committed are different institutions. Most organisations have built the second.
Why portfolio leaders need disciplined measures for capability, learning, safety, resilience and future options alongside immediate financial returns.
Why scope, time and cost are necessary but insufficient measures of success, and how leaders should connect project constraints to enterprise value.
Why procurement timing and strategy must be aligned with funding authority, budget structure, work packages and the enterprise value expected from capital.
Why the economic character, lifecycle and reversibility of expenditure should influence sourcing, contract structure and procurement governance.
Why project budgets must connect authorised cost, cash flow, capacity, sequencing and portfolio opportunity cost across the investment lifecycle.
How executives should interpret project cost estimates through evidence, maturity, uncertainty and the consequences of irreversible commitments.
Half of the estimating loop consumes a database of past projects. The other half fills it — and only the consuming half is paid for by a project that benefits.
Quality sits in operations and its cost sits nowhere. Until finance can produce the number, prevention will always lose the argument to correction.
The register that authorises and carries risk treatment has no field for what the treatment costs, so controls are bought on gross benefit and never on net.
Make-or-buy is usually argued on unit cost. The margin most firms think they gain by making is conditional on scale they may not have.
A strategic framework for deciding when more evidence is worth its cost, when experimentation should precede commitment and when delay destroys value.
Optimistic forecasts are usually blamed on weak estimating. The more useful explanation is that the number was produced by the party who needed the answer to be yes.
How breakeven reveals the usage threshold between sourcing options while utilisation, obsolescence and reversibility determine the stronger enterprise choice.
Affordability is only one test of investment quality. Leaders must also challenge strategic fit, value, commercial viability and deliverability.
A market position is a commitment that reprices purchasing, quality, hiring and technology. If only the messaging changed, the position was never chosen at all.
Enterprise systems are usually chosen before the problem is defined. The tests that separate buying a capability from inheriting a fragmented estate.
Expansion readiness is a property of the acquirer, not the target. The tests that separate deploying surplus capacity from betting that scale repairs a model.
What your asset must be built to withstand is set by land you do not own and a decision you are not party to, and it can be reset after your capital is committed.
Repeat purchase and referral are different economic engines with different capital logic. Most enterprises instrument and forecast the one they lack.
Exclusive infrastructure buys a lead measured in months and a cost base measured in years. How to judge when shared capacity beats owning the asset alone.
A growth bet funded from the business that pays for it becomes a bet you cannot stop. Why the separately capitalised vehicle is a governance decision.
Some enterprises stopped making things and started orchestrating projects. The model moves where margin sits, and imports a failure profile along with it.
Why growth can weaken cash and strategic freedom, and how leaders should distinguish productive reinvestment from capital consumption and delayed maintenance.
Most AI initiatives have a launch date and no stopping condition. Three dispositions against a measured human benchmark turn that into a capital decision.
Embedded features and internal tools have different owners, economics, risks and failure modes. Most organisations fund one of them and measure the other.